About Us
Biomarkers at Fawkes Biotechnology
Our company is helping to bring clarity to concussions. Clinical human studies indicate that our patented biomarker Point of Care in vitro device can determine with a drop of blood if a concussive event has occurred within 15 minutes. We plan to continue furthering development stages and seek FDA approval in the future.